Cellectar Biosciences
Utility Patent Applications

Last updated:

List of all Cellectar Biosciences patents 2 in total

Status Patent
Application
Utility: Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy External link
Filling date: 6 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer External link
Filling date: 6 Sep 2025 Issue date: 15 Apr 2021

Showing 1 to 2 of 2 patents.